| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 2015 | 2016 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.957 | 2 | 0 | 2000 | 2018 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
group | 0.400 | None | 0.895 | 2 | 0 | 2003 | 2019 | ||||||||
|
metastasis associated lung adenocarcinoma transcript 1 | 0.435 | 0.846 |
|
group | 0.330 | None | 1.000 | 2 | 0 | 2015 | 2019 | |||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
group | 0.400 | None | 0.950 | 2 | 0 | 2002 | 2019 | ||||||||
|
cytochrome P450 family 1 subfamily B member 1 | 0.457 | 0.769 | 2.2E-05 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 1995 | 2009 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 2001 | 2019 | ||||||||
|
fatty acid synthase | 0.474 | 0.846 | 1.00 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 1999 | 2017 | ||||||||
|
baculoviral IAP repeat containing 5 | 0.495 | 0.731 | 5.6E-02 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 2005 | 2008 | ||||||||
|
uridine monophosphate synthetase | 0.584 | 0.615 | 1.1E-04 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2008 | 2009 | ||||||||
|
vascular endothelial growth factor C | 0.459 | 0.769 | 0.50 |
|
group | 0.400 | None | 0.917 | 2 | 0 | 2003 | 2017 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
group | 0.390 | None | 1.000 | 2 | 0 | 2000 | 2018 | ||||||||
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 0.488 | 0.769 | 0.74 |
|
group | 0.340 | None | 1.000 | 2 | 0 | 2002 | 2012 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
group | 0.360 | None | 1.000 | 2 | 0 | 2004 | 2009 | ||||||||
|
transferrin receptor | 0.437 | 0.885 | 7.0E-05 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2006 | 2015 | ||||||||
|
DNA methyltransferase 3 beta | 0.453 | 0.846 | 0.20 |
|
group | 0.340 | None | 0.800 | 2 | 0 | 2003 | 2018 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 1990 | 2019 | ||||||||
|
progesterone receptor | 0.426 | 0.885 | 5.1E-02 |
|
group | 0.400 | None | 0.981 | 2 | 0 | 1991 | 2020 | ||||||||
|
zinc finger E-box binding homeobox 1 | 0.442 | 0.808 | 0.97 |
|
group | 0.380 | None | 1.000 | 2 | 0 | 2007 | 2018 | ||||||||
|
dihydrofolate reductase | 0.513 | 0.808 | 3.4E-02 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2011 | 2017 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 2004 | 2019 | ||||||||
|
hes family bHLH transcription factor 1 | 0.468 | 0.885 | 0.71 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2007 | 2010 | ||||||||
|
H2A.X variant histone | 0.484 | 0.808 | 0.18 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2008 | 2011 | ||||||||
|
cyclin E1 | 0.538 | 0.731 | 0.97 |
|
group | 0.370 | None | 1.000 | 2 | 0 | 2002 | 2013 | ||||||||
|
breast cancer anti-estrogen resistance 4 | 0.653 | 0.346 |
|
group | 0.330 | None | 1.000 | 2 | 0 | 2006 | 2011 |